- Home /
- Services /
- Preclinical studies
leave a request
Preclinical studies are an integral stage in the development and introduction of new drugs into clinical practice. The main tasks in the process of preclinical studies are the study of the pharmacodynamics and pharmacokinetics of the study drug, its toxic and pharmaceutical properties, the minimum toxic dose is determined, and the efficacy and safety are evaluated.
AX CT provides services for the organization of preclinical studies of medicines (pharmaceutical substances and drugs) in accordance with the requirements of international GLP rules.
Preclinical drug safety studies are aimed at identifying a possible damaging effect of drugs and assessing the safety of its use. Such studies are conditionally divided into two large blocks: a study of general toxicity and a study of specific toxicity. Preclinical efficacy studies – assessment of the pharmacological activity of a potential drug for the treatment of a particular disease, as well as the pharmacodynamic properties of drugs. This type of research is carried out on models of laboratory animal diseases and is the basis for the development of indications for use and the design of further clinical studies.
Preclinical studies are a necessary step in the registration of:
You can provide only the molecule name, and we will develop the entire strategy for bringing the drug to market: from designing, calculating the sample size, selecting a reference drug, its procurement (in the Russian Federation or import), to writing the final report on the conducted research and submitting it to regulatory authorities.
Fill out the feedback form and we will provide you with a set of documents, which includes: